Skip to content

Bristol-Myers Squibb BMY Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin70.5%-0.6pp71.1%+1.6pp69.5%-0.8pp70.3%-0.2pp70.5%-0.6pp
Net margin15%+0.4pp14.6%+2.2pp12.4%+2.0pp10.4%-0.8pp11.2%+29.9pp
Returns
Return on equity38.8%-1.7pp40.5%+7.1pp33.4%+4.5pp28.9%-2.7pp31.6%+71.0pp
Return on invested capital13%+0.5pp12.5%+2.0pp10.6%+2.2pp8.3%-0.5pp8.8%+23.5pp
Efficiency
Asset turnover0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×
Liquidity
Current ratio1.4×+0.2×1.3×0.0×1.3×+0.1×1.2×-0.1×1.3×0.0×
Leverage
Debt-to-equity2.2×-0.3×2.6×-0.1×2.7×-0.2×2.8×0.0×2.9×-0.3×
Net debt / EBITDA2.7×-0.1×2.8×+0.1×2.6×-0.2×2.8×+0.1×2.8×-36.3×
Valuation
Market capitalization$123.83B+12.8%$109.81B+19.6%$91.8B-4.1%$95.71B-22.9%$124.1B+8.2%
Price / earnings17×+1.5×15.6×+0.2×15.4×-3.8×19.2×-4.0×23.2×
Price / sales2.6×+0.3×2.3×+0.4×1.9×-0.1×-0.6×2.6×+0.2×
Price / book6.2×+0.2×5.9×+1.0×4.9×-0.5×5.5×-1.6×7.1×+0.1×
EV / EBITDA12×+1.0×11×+1.2×9.8×-0.5×10.3×-1.4×11.6×-137×
Dividend yield4.1%-0.5pp4.6%-0.9pp5.4%+0.3pp5.2%+1.2pp4%-0.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Bristol-Myers Squibb's ratios come from?
Every ratio is computed from Bristol-Myers Squibb's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.